Half-year report · Q2

Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥60.6bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥118.6bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥57.5bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income¥808m2024-07-01 → 2024-12-31Cons.Operating income
Operating income¥747m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income¥824m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income¥2.2bn2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥746m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax¥816m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax¥745m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥648m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥486m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income¥648m2024-07-01 → 2024-12-31Cons.Profit loss
Net income¥486m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥46.8bnat 2024-12-31Cons.Assets
Total assets¥43.2bnat 2024-06-30Cons.Assets
Total assets¥43.4bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥35.3bnat 2024-12-31Cons.Liabilities
Total liabilities¥31.9bnat 2024-06-30Cons.Liabilities
Net assets / equity¥11.5bnat 2024-12-31Cons.Net assets
Net assets / equity¥11.4bnat 2024-06-30Cons.Net assets
Net assets / equity¥10.2bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥2.7bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥2.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow−¥800m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥146m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥889m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥673m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥347m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.5bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.1bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.0bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥109.442024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥251.682023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥81.012023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio24.6%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.3%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥880m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥880m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥67m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2024-07-01 → 2024-12-31¥1.4bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.4bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥19,000
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2024-07-01 → 2024-12-31¥105m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2024-07-01 → 2024-12-31¥57.3bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥56.5bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥816m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥715m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2024-07-01 → 2024-12-31¥2.8bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2024-07-01 → 2024-12-31¥2.8bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥64m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2024-07-01 → 2024-12-31¥55m
Total Of Reportable Segments And Otherssegment totalrevenue2024-07-01 → 2024-12-31¥61.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-07-01 → 2024-12-31¥60.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-07-01 → 2024-12-31¥880m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-07-01 → 2024-12-31¥875m
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥725m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥725m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥76m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue2023-07-01 → 2023-12-31¥1.3bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.3bn
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segmentsegment profit2023-07-01 → 2023-12-31¥102m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue2023-07-01 → 2023-12-31¥54.3bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥53.6bn
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥656m
jpcrp040300-q2r_E02928-000Medical Equipmentreportable segmentsegment profit2023-07-01 → 2023-12-31¥669m
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue2023-07-01 → 2023-12-31¥2.6bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue external2023-07-01 → 2023-12-31¥2.5bn
jpcrp040300-q2r_E02928-000SPDreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥68m
jpcrp040300-q2r_E02928-000SPDreportable segmentsegment profit2023-07-01 → 2023-12-31¥52m
Total Of Reportable Segments And Otherssegment totalrevenue2023-07-01 → 2023-12-31¥58.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-07-01 → 2023-12-31¥57.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-07-01 → 2023-12-31¥725m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2023-12-31¥823m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 522
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember410000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0664
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember300000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0485
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember278000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0451
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember277000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0449
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember262000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0425
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember186000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0302
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember165000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0267
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember151000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0244
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember149000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0242
Number of shares heldCurrentQuarterInstant3040000
Shareholding ratioCurrentQuarterInstant0.4919
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember70200
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember6170600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember61706
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember9200
Number of shares issued shares voting rightsCurrentQuarterInstant6250000
Number of voting rights issued shares voting rightsCurrentQuarterInstant61706
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member70200
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member70200
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0112
Number of shares held in own name treasury shares etcCurrentQuarterInstant70200
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant70200
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0112
Cash and depositsPrior1YearInstant2731386000JPY
Cash and depositsCurrentQuarterInstant2643470000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant22474601000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant24396286000JPY
Electronically recorded monetary claims operating caPrior1YearInstant3623819000JPY
Electronically recorded monetary claims operating caCurrentQuarterInstant3412717000JPY
MerchandisePrior1YearInstant5943369000JPY
MerchandiseCurrentQuarterInstant7165494000JPY
Other caPrior1YearInstant812879000JPY
Other caCurrentQuarterInstant639245000JPY
Current assetsPrior1YearInstant35586056000JPY
Current assetsCurrentQuarterInstant38257214000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass